ATE299186T1 - Rekombinanter vektor zur gentherapie für insulin- abhängige diabetes mellitus und therapeutische zusammensetzungen davon - Google Patents

Rekombinanter vektor zur gentherapie für insulin- abhängige diabetes mellitus und therapeutische zusammensetzungen davon

Info

Publication number: ATE299186T1
Authority: AT; Austria
Prior art keywords: insulin; diabetes mellitus; expression; dependent diabetes; gene
Prior art date: 2001-01-15

Application number

AT01103348T

Other languages

English (en)

Inventor

Dongsang Suh

Jangan-Ku Chunchun-Dong

Original Assignee

Suh Dongsang Dept Genetic Engi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-15

Filing date

2001-02-13

Publication date

2005-07-15

2001-02-13 Application filed by Suh Dongsang Dept Genetic Engi filed Critical Suh Dongsang Dept Genetic Engi

2005-07-15 Application granted granted Critical

2005-07-15 Publication of ATE299186T1 publication Critical patent/ATE299186T1/de

Links

239000013598 vector Substances 0.000 title abstract 4
206010067584 Type 1 diabetes mellitus Diseases 0.000 title abstract 3
238000001415 gene therapy Methods 0.000 title abstract 3
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 2
108010005774 beta-Galactosidase Proteins 0.000 abstract 2
239000013604 expression vector Substances 0.000 abstract 2
238000002347 injection Methods 0.000 abstract 2
239000007924 injection Substances 0.000 abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
210000002510 keratinocyte Anatomy 0.000 abstract 2
210000003491 skin Anatomy 0.000 abstract 2
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
241001529936 Murinae Species 0.000 abstract 1
241000699670 Mus sp. Species 0.000 abstract 1
102000008579 Transposases Human genes 0.000 abstract 1
108010020764 Transposases Proteins 0.000 abstract 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 abstract 1
102000005936 beta-Galactosidase Human genes 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1
239000002502 liposome Substances 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000000496 pancreas Anatomy 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
238000010186 staining Methods 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4741—Keratin; Cytokeratin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

AT01103348T 2001-01-15 2001-02-13 Rekombinanter vektor zur gentherapie für insulin- abhängige diabetes mellitus und therapeutische zusammensetzungen davon ATE299186T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR10-2001-0002229A KR100418465B1 (ko)	2001-01-15	2001-01-15	인슐린 의존성 당뇨병의 유전자 치료방법 및 그 치료용 조성물

Publications (1)

Publication Number	Publication Date
ATE299186T1 true ATE299186T1 (de)	2005-07-15

Family

ID=36120927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01103348T ATE299186T1 (de)	2001-01-15	2001-02-13	Rekombinanter vektor zur gentherapie für insulin- abhängige diabetes mellitus und therapeutische zusammensetzungen davon

Country Status (7)

Country	Link
US (1)	US6596515B2 (de)
EP (1)	EP1223221B1 (de)
JP (1)	JP3538148B2 (de)
KR (1)	KR100418465B1 (de)
CN (1)	CN1202257C (de)
AT (1)	ATE299186T1 (de)
DE (1)	DE60111818T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2010003371A (es)	2007-09-28	2010-05-05	Intrexon Corp	Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
CN116925985A (zh) *	2022-03-30	2023-10-24	华东师范大学	智能可控的微生物药物工厂及其在皮肤伤口愈合中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6225121B1 (en) *	1992-09-14	2001-05-01	Institute Of Molecular Biology And Biotechnology/Forth	Eukaryotic transposable element
US6770460B1 (en) *	1998-01-29	2004-08-03	Wallac Oy	Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus
WO2001071018A2 (en) *	2000-03-22	2001-09-27	Board Of Trustees Of The University Of Arkansas	Secreting products from skin by adeno-associated virus (aav) gene transfer

2001
- 2001-01-15 KR KR10-2001-0002229A patent/KR100418465B1/ko not_active Expired - Fee Related
- 2001-01-26 JP JP2001019261A patent/JP3538148B2/ja not_active Expired - Fee Related
- 2001-02-05 US US09/775,508 patent/US6596515B2/en not_active Expired - Fee Related
- 2001-02-13 DE DE60111818T patent/DE60111818T2/de not_active Expired - Fee Related
- 2001-02-13 EP EP01103348A patent/EP1223221B1/de not_active Expired - Lifetime
- 2001-02-13 AT AT01103348T patent/ATE299186T1/de not_active IP Right Cessation
- 2001-02-28 CN CNB011043709A patent/CN1202257C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2002218987A (ja)	2002-08-06
EP1223221A2 (de)	2002-07-17
DE60111818D1 (de)	2005-08-11
KR100418465B1 (ko)	2004-02-14
CN1366062A (zh)	2002-08-28
EP1223221B1 (de)	2005-07-06
EP1223221A3 (de)	2002-09-04
CN1202257C (zh)	2005-05-18
US6596515B2 (en)	2003-07-22
DE60111818T2 (de)	2006-04-20
US20030054498A1 (en)	2003-03-20
KR20020061270A (ko)	2002-07-24
JP3538148B2 (ja)	2004-06-14

Legal Events

Date	Code	Title	Description
2006-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
US11149262B2 (en)	2021-10-19	Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation
DE69535264T2 (de)	2007-02-01	Verfahren zur behandlung von diabetes mittels kgf
US20060165657A1 (en)	2006-07-27	Method for delivery of cosmetic by topical application
TW201709928A (zh)	2017-03-16	用於促進傷口癒合之組成物
Hamoudi et al.	2016	Identification and characterization of the corazonin receptor and possible physiological roles of the corazonin-signaling pathway in Rhodnius prolixus
ATE460183T1 (de)	2010-03-15	Viraler vektor zur verwendung in der in-vivo- gentherapie von morbus parkinson
CN102209784B (zh)	2013-11-27	骨膜素诱导的胰腺再生
WO2018104479A1 (en)	2018-06-14	Inhibitors of mechanotransduction to treat pain and modulate touch perception
DE60111818D1 (de)	2005-08-11	Rekombinanter Vektor zur Gentherapie für Insulin-abhängige Diabetes mellitus und therapeutische Zusammensetzungen davon
JP2010519192A (ja)	2010-06-03	瘢痕の抑制のためのｗｎｔ３ａ
JPH10279501A (ja)	1998-10-20	育毛剤
US20100261659A1 (en)	2010-10-14	Secreted frizzled related protein 3 for use in the inhibition of scarring
US20100137201A1 (en)	2010-06-03	Medicaments
Sita et al.	2019	Nomenclature and comparative morphology of the teneurin/tcap/adgrl protein families
WO2024219827A1 (ko)	2024-10-24	Cpne7단백질 유래 펩타이드를 포함하는 피부 노화억제 또는 상처치료용 조성물
BRPI0409984A (pt)	2006-05-09	processo para alterar a farmacocinética da insulina
Hirano	2011	Tissue engineering for voice disorder
KR20250121164A (ko)	2025-08-11	치료법 및 화장품에 사용하기 위한 sarm1 제제
Herrera-Cepeda et al.	2007	Successful Peripheral Stem Cell Autologous Engraftment in Skin of a Patient with Severe Dermal Atrophy and Senile Purpura. First Venezuelan Report.